Specialty Account Manager, Symbravo (Davenport, IA)

About this role

<p>Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D9IV8MzSvfOHVeWvrQ7Gpyyjf8oh2YbOImEae8XHfJeeKdWb5iMTG_i6gTGCiHtoMzE1iVTUEQk7IBNDvtrd8dbwJfMAYLK1NiNGH8FOf8LVClDRvtC2QLJLwxcJsj8r1Ife70mjBMpRU8D5q5PfAvDP5AbMwldlIcg5842srmwDavyrAg8tK_VpiNRaKqPlOSPLrCg1Yr2Gqdo5K6iwgZGVlm_WvFI8bMuPXMrqlgRQ%3D&data=05%7C02%7Cmsiegel%40axsome.com%7Cb0ad9a0787784e7305e308dda9c74deb%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C638853395639171980%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=dWf%2FLVmCejjY3pM4XQok9nH8pF%2BfGwqWCZ8QwdWpTGQ%3D&reserved=0"><strong>www.axsome.com</strong></a> and follow us on <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DgkOAMVaudmIbjNO4LWBtZ25_8dkwL1L91EK22smznktgIMuoh5PltUd03J1ZN68KtUufEmLQRMgUjKqoa2Pb1ADSKI0zgay-rDcXd0R2wsbi9WIetngm8x8P1QX9OxhZQzuoPJMXr0UXnyGnIAbSvjwOT0oODGh2y6eODJbInNknBhQ4fXiSCd0LwP8PlS9T_Er2Q-RAoqsN_pVSx0k80cO9ivcvtqdJxZGSzZ37Ytmfmq-AThjSdP9ltWSUa2Fx&data=05%7C02%7Cmsiegel%40axsome.com%7Cb0ad9a0787784e7305e308dda9c74deb%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C638853395639206174%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=ZofAOfLit%2FDztSC9U2W1xpx9HHF9z5bb4r1JDK9%2FVzo%3D&reserved=0"><strong>LinkedIn</strong></a> and <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DU4SjZsngAmgWDPNMBXhPfrWmLydithQ9boBRvsxUVxU58ik7Xm8tTepHofb6vjZMJpx1MvqLvCWWZ1wdmggQxeoNBfHWoTcIMhguJ4Da2DlcZj5Ye9BIcFvHHFTGURb_iGqk28bMXOs7pE8QmOShf7wSgJ0OVuMRyY31jlih0__WG9Q4dmEjE86yUY_8J0qo&data=05%7C02%7Cmsiegel%40axsome.com%7Cb0ad9a0787784e7305e308dda9c74deb%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C638853395639221688%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=Y85uAjK%2B8ysZNvbrHQAmApGPYT7mUKwtYyw%2FV0cvCcE%3D&reserved=0"><strong>X</strong></a>.</p> <p><strong>About This Role</strong></p> <p><span data-contrast="auto"><span data-ccp-parastyle="Body Text">Axsome</span> <span data-ccp-parastyle="Body Text">Therapeutics</span> <span data-ccp-parastyle="Body Text">is</span> <span data-ccp-parastyle="Body Text">seeking</span> <span data-ccp-parastyle="Body Text">a</span> <span data-ccp-parastyle="Body Text">Specialty</span> <span data-ccp-parastyle="Body Text">Account</span> <span data-ccp-parastyle="Body Text">Manager</span> <span data-ccp-parastyle="Body Text">(SAM)</span> <span data-ccp-parastyle="Body Text">to</span> <span data-ccp-parastyle="Body Text">execute</span> <span data-ccp-parastyle="Body Text">commercial</span> <span data-ccp-parastyle="Body Text">activities</span> <span data-ccp-parastyle="Body Text">for</span> an <span data-ccp-parastyle="Body Text">assigned</span> <span data-ccp-parastyle="Body Text">geography,</span> <span data-ccp-parastyle="Body Text">establish</span> <span data-ccp-parastyle="Body Text">relationships</span> <span data-ccp-parastyle="Body Text">with</span> <span data-ccp-parastyle="Body Text">customers, and ensure successful promotion of SYMBRAVO, an oral acute migraine medication. </span></span><span data-contrast="auto"><span data-ccp-parastyle="Body Text">SAM</span><span data-ccp-parastyle="Body Text">s</span> <span data-ccp-parastyle="Body Text">will</span> <span data-ccp-parastyle="Body Text">be</span> <span data-ccp-parastyle="Body Text">responsible</span> <span data-ccp-parastyle="Body Text">for</span> <span data-ccp-parastyle="Body Text">product</span> <span data-ccp-parastyle="Body Text">performance</span> <span data-ccp-parastyle="Body Text">at</span> <span data-ccp-parastyle="Body Text">a</span> <span data-ccp-parastyle="Body Text">territory</span> <span data-ccp-parastyle="Body Text">level</span> <span data-ccp-parastyle="Body Text">and expected to be a disease</span>…